Alloy Therapeutics enters multi-year collaboration with Pfizer to develop new antibody discovery platform: Boston, Massachusetts Thursday, February 13, 2025, 13:00 Hrs [IST] Alloy ...

Boston: Alloy Therapeutics Inc., a biotechnology ecosystem company has announced its latest strategic collaboration with ...

Alloy Therapeutics Inc., a biotechnology ecosystem company, has joined forces with Pfizer Inc., to develop a new platform ...

Privately-held Alloy Therapeutics has announced a new multi-year collaboration with Pfizer to develop a bespoke platform that ...

Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

Pfizer (NYSE:PFE) has entered into a multi-year collaboration with Alloy Therapeutics to develop a new antibody discovery platform. Under the deal, Alloy will receive an upfront payment from Pfizer ...

Explore how Medicare drug price negotiations under the Inflation Reduction Act could evolve with the Trump administration.

As March draws near, Americase and Shmuel De-Leon Energy Ltd. urge industry professionals to register for the upcoming Navigating Battery Safety, Regulations & Innovation Symposium, taking place on ...

Tempus AI, Inc. , a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, February 24, 2025.

Vedanta, Nuvama, Punjab National Bank, IndusInd Bank, and Bandhan Bank will be among 135 companies to release their reports ...

HELSINKI - Afarak Group SE (LSE: AFRK, NASDAQ: AFAGR), a manufacturer of specialty metal alloys, held an extraordinary general meeting in Helsinki on January 29, 2025, where it was decided to ...